“…Also, DNA vaccination with several different ORFs has been tested for IcHV-1 (Nusbaum et al, 2002). Later, an overlapping and a full BAC have been developed for IcHV-1 (Kunec et al, 2008) and CyHV-3 (Costes et al, 2008), respectively. The latter was used to test attenuation after disruption of the thymidine kinase locus and deletion of ORF16.…”